Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore S Hong

Showing results (101-110 of 306) with videos related to

Pageof 31
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 12, 2013
Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patientsYading Yuan, Ovidiu C Andronesi, Thomas R Bortfeld, et al.
American Journal of Clinical Oncology|December 20, 2007
Megavoltage computed tomography: an emerging tool for image-guided radiotherapyTheodore S Hong, James S Welsh, Mark A Ritter, et al.
The Oncologist|October 2, 2015
Familial Gastric CancersNamrata Setia, Jeffrey W Clark, Dan G Duda, et al.
Cancers|May 16, 2023
MRI-Based Tumor Necrosis Depiction in Pancreatic Ductal Adenocarcinoma: Can It Predict Tumor Aggressiveness?Mark A Anderson, David E Knipp, Yoshifumi Noda, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality studyTheodore S Hong, Minesh P Mehta, James M Boyett, et al.
Seminars in Radiation Oncology|June 7, 2020
Challenges in Reirradiation of Intrahepatic TumorsDawn Owen, Jelena Lukovic, Ali Hosni, et al.
Practical Radiation Oncology|November 25, 2015
Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trialJoshua R Niska, Florence K Keane, John A Wolfgang, et al.
JCO Oncology Practice|May 30, 2020
Silver Linings: An Opportunity to Improve Clinical Paradigms After the COVID-19 PandemicHannah I Hoffman, Jimmy A Guo, Maria A Hawkins, et al.
Practical Radiation Oncology|October 19, 2017
Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancerJennifer L Pretz, Michael A Blake, Joseph H Killoran, et al.
Nature Reviews. Clinical Oncology|March 18, 2023
Neoadjuvant therapy for pancreatic cancerChristoph Springfeld, Cristina R Ferrone, Matthew H G Katz, et al.
Pageof 31

Showing results (101-110 of 306) with videos related to

Sort By:
Pageof 31
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 12, 2013
Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patientsYading Yuan, Ovidiu C Andronesi, Thomas R Bortfeld, et al.
American Journal of Clinical Oncology|December 20, 2007
Megavoltage computed tomography: an emerging tool for image-guided radiotherapyTheodore S Hong, James S Welsh, Mark A Ritter, et al.
The Oncologist|October 2, 2015
Familial Gastric CancersNamrata Setia, Jeffrey W Clark, Dan G Duda, et al.
Cancers|May 16, 2023
MRI-Based Tumor Necrosis Depiction in Pancreatic Ductal Adenocarcinoma: Can It Predict Tumor Aggressiveness?Mark A Anderson, David E Knipp, Yoshifumi Noda, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality studyTheodore S Hong, Minesh P Mehta, James M Boyett, et al.
Seminars in Radiation Oncology|June 7, 2020
Challenges in Reirradiation of Intrahepatic TumorsDawn Owen, Jelena Lukovic, Ali Hosni, et al.
Practical Radiation Oncology|November 25, 2015
Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trialJoshua R Niska, Florence K Keane, John A Wolfgang, et al.
JCO Oncology Practice|May 30, 2020
Silver Linings: An Opportunity to Improve Clinical Paradigms After the COVID-19 PandemicHannah I Hoffman, Jimmy A Guo, Maria A Hawkins, et al.
Practical Radiation Oncology|October 19, 2017
Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancerJennifer L Pretz, Michael A Blake, Joseph H Killoran, et al.
Nature Reviews. Clinical Oncology|March 18, 2023
Neoadjuvant therapy for pancreatic cancerChristoph Springfeld, Cristina R Ferrone, Matthew H G Katz, et al.
Pageof 31